CHA Group Site

Korea Research-Driven Hospitals

Development of patient-derived somatic cell nuclear transfer (SCNT) stem cell therapeutic agent for degenerative retinal disease patients
Development of placental stem cell therapeutic agent for traumatic optic nerve disease

Development of mesenchymal stem cell treatment technology for spinal functional improvement of degenerated intervertebral disc patients
Development of adipose tissue-derived stem cell treatment technology for arthritis patients
Development of adipose tissue-derived stem cell treatment technology for cartilage injury

Development of embryo-derived neural precursor cell transplantation technology for Parkinson’s disease
Development of umbilical cord-derived mesenchymal stem cell treatment technology for ischemic stroke
Development of combined allogeneic umbilical cord blood and erythropoietin treatment technology for cerebral palsy
Development of placenta-derived mesenchymal stem cell treatment technology for Alzheimer disease
Development of placenta-derived mesenchymal stem cell treatment technology for brain damage after cardiac arrest

Discovery of premature ovarian failure-related causative genomic changes, and development of new diagnostic and treatment technology for premature ovarian failure
Development of allogeneic umbilical cord stem cell therapeutic agent for Asherman’s syndrome

Premature aging mechanism-related biomarker research and anti-aging treatment target research for chronic renal insufficiency patients
Development of in vitro model of dermatologic aging and high speed mass screening technology of anti-aging material /blood vessel-inclusive artificial skin development

Development of cancer gene therapeutic agent using cancer cell-specific killer virus vector
Development of targeted therapy for cancer stem cells/Investigation of immune therapy resistance mechanism and biomarker research
Chemoquiescence through seletive elimination of cancer stem cells and Clinical implementation of stem cell-based chemoprevention (siTRP strategy)
Development of diagnostic kits and theranostics for ovarian cancer therapeutic response prediction using chemoresistant ovarian cancer-specific biomarker

Comprehensive
Anti-aging Life
Centers

Domestic
Medical Centers

Overseas
Medical Centers

CHA University

Medical Exam
Centers

Affiliates/Medical
Business Divisions

59, Yatap-ro, Bundang-gu, Seongnam, Gyeonggi-do, Korea

LANGUAGES